Welcome to Feed the Bull - A home for investment information and interaction.


Hologic Splashes Out $3.72 Billion for Gen-Probe

Posted, by Benzinga on April 30th, 2012

It was revealed on Monday that Hologic (NASDAQ: HOLX) is set to purchase Gen-Probe (NASDAQ: GPRO) for approximately $3.72 billion. This is an all-cash deal that will see the Bedford, Mass.-based company pay $82.75 for each GPRO share. The move will see HOLX seek to broaden its diagnostics business.

"This transaction establishes Hologic as a premier company in [sexually transmitted disease] diagnostics and advances our core focus on women's health," said Rob Cascella, Hologic's CEO, adding that it will help the company "capitalize on the fast-growing molecular diagnostics market with an established global infrastructure."

Authored by, Benzinga
Log in or register to post Private Message
Advertise with us

Add new comment

By submitting this form, you accept the Mollom privacy policy.